PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 83: Articles 41001-41500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Effect of oral contraceptives on depressive mood changes and on endometrial monoamine oxidase and phosphatases.
  2. Effects of a family planning program on the fertility of a marginal working-class community in Santiago.
  3. Effects of contraceptive steroids on carbohydrate metabolism.
  4. Effects of low-dose oral contraceptives on blood coagulation.
  5. Effects of oral contraceptives and pregnancy on thyroid function.
  6. The effects of oral contraceptives on glucose tolerance.
  7. The effects of oral contraceptives on the endometrium. I. Blood vessels.
  8. Effects of oral contraceptives upon the cytology of the female generative tract.
  9. Emotional factors in oral contraception.
  10. Endocervical inhibition of sperm capacitation by norgestrel contraception.
  11. England and Wales: general practitioners and family planning.
  12. England and Wales: general practitioners and family planning. (summary)
  13. Erythema nodosum from oral contraceptives.
  14. Essay on the calculation of the effectiveness of contraception. [Essai de calcul de l'efficacite de la contraception.]
  15. Evaluation and recordkeeping for U.S. family planning services.
  16. Evaluation of a plastic intrauterine loop in a postpartum family planning program.
  17. Evaluation of induced abortion control and family planning programs in Chile.
  18. Evaluation of ORF-1658, a new formulation for sequential oral contraceptive therapy.
  19. Evaluation of the family planning program in Taiwan, Republic of China.
  20. Evaluation techniques in family planning.
  21. Experience with ethynodiol diacetate and mestranol as an oral contraceptive.
  22. Experience with oral contraception in the Thai patients.
  23. Experience with oral contraception in the United States, 1960-1965.
  24. Experience with oral contraceptives.
  25. Experience with the plastic intra-uterine contraceptive device in Lagos, its effectiveness, acceptability and safety.
  26. Experience with the use of intrauterine contraceptive devices.
  27. Experiences in motivation and promotion of family planning in Singapore.
  28. Experiences in the use of communication methods in promoting family planning in Hong Kong.
  29. An experiment in bringing family planning to the poor: final report.
  30. An experiment in bringing family planning to the poor: second progress report, April 1, 1967 to March 31, 1968.
  31. Experimental and clinical aspects of the carcinogenic potential of steroid contraceptives.
  32. Family planning and demography. [Planification familiale et demographie.]
  33. Family planning and other population controls. (Letter)
  34. Family planning and our Latin American colleagues.
  35. Family planning and public health.
  36. Family planning and public policy: is the "culture of poverty" the new cop-out?
  37. Family planning movement.
  38. Family planning or birth control?
  39. A family planning programme for Nigeria.
  40. The family planning programme in the organised sector of Delhi.
  41. The family planning programme: a review and assessment.
  42. Family planning programs in the U.S.
  43. Family planning programs of the Office of Economic Opportunity: scope, operation, and impact.
  44. Family planning service in a voluntary hospital.
  45. Family planning services in hospital.
  46. FAmily planning targets in India for the next five years.
  47. Family planning: a guide for state and local agencies.
  48. Family planning: a major public health programme in India.
  49. Family planning: attitudes and practices in a suburban area of Thailand.
  50. Family planning: humanism and science.
  51. Family size, contraception, and birth rate before and after the introduction of a new method of family planning.
  52. Fatal thromboembolic accident following contraceptive "pill". [Accident thrombo-embolique mortel apres "pilule" contraceptive.]
  53. Fertile life span of rabbit spermatozoa in the presence of an intrauterine contraceptive device.
  54. Fertility after discontinuance of intrauterine and oral contraception.
  55. Fertility and poverty in the United States: some implications for family-planning programs, evaluation, and research.
  56. Fertility and the need for family planning among the rural poor in the United States.
  57. Field experience with modern contraceptives.
  58. Field study of an oral contraceptive among IUD drop-outs in rural Korea.
  59. Fine structural effects of intrauterine contraceptives on the human endometrium,.
  60. First comparative evaluation of the pilot services of family planning. [Primera valoracion comparativa de los servicios piloto de planificacion familiar.]
  61. Florid breast fibroadenomas in patients taking hormonal oral contraceptives.
  62. From now to zero: fertility, contraception and abortion in America.
  63. Functional and morphological liver changes in women taking oral contraceptives.
  64. Genetic counselling in family planning.
  65. Georgia's family planning program.
  66. Ghana. (Family planning)
  67. Glucose and insulin alterations after one year of combination-type oral contraceptive treatment.
  68. Gonorrhoea and the intrauterine contraceptive device.
  69. Government's role in family planning.
  70. Grenada. (Family planning)
  71. A handbook for service statistics in family planning programs.
  72. Herpes gestationis influenced by an oral contraceptive.
  73. High blood pressure and oral contraceptives: changes in plasma renin and renin substrate and in aldosterone excretion.
  74. Histological changes in the ovaries and the endometrium under the effect of intra-uterine contraceptive device.
  75. Hong Kong: an evaluation of field workers and decision making in family planning programs.
  76. Hormonal contraception and cardiac infarction. [Hormonell antikonsepsjon og hjerteinfarkt.]
  77. Hormonal contraception. [Die hormonale Kontrazeption.]
  78. Hormonal contraception. [La contraception hormonale.]
  79. Hormonal steroids in contraception: Report of a WHO scientific group.
  80. Hormone contraception: blood coagulation studies.
  81. Hormone contraception: liver function and other biochemical studies.
  82. Hormone contraception: ophthalmologic investigations.
  83. Hormone Contraception: Studies of Adrenal Function.
  84. How are we doing in family planning in India?
  85. A huge marketing research task - birth control.
  86. A hugh marketing research task: birth control.
  87. Hypertriglyceridemia during treatment with estrogen and oral contraceptives.
  88. The impact of family planning on fertility in Comilla.
  89. Inaugural address (on family planning)
  90. Incentives, disincentives and extension education for family planning.
  91. The incidence of side effects with oral or intrauterine contraceptives.
  92. An independent summing up of the seminar. (Family planning and population policy in Africa)
  93. Indexes for measurement of amount of contraceptive practice.
  94. India's family planning programme: what we have accomplished so far.
  95. India: the family planning program since 1965.
  96. India: the family planning program since 1965.
  97. Indications of intra-uterine ring contraception, based on a clinical and pathological study in 130 cases.
  98. Infarction of the midgut associated with oral contraceptives.
  99. The influence of timing of contraception. [Influence du calendrier de la contraception.]
  100. Injectable approach to hormonal contraception.
  101. Intensive promotion of family planning in the industrial sector.
  102. The International Planned Parenthood Federation (IPPF)
  103. The International Planned Parenthood Federation - its role in developing countries.
  104. Interpersonal influence in family planning in Puerto Rico.
  105. Intra-uterine contraception: research report.
  106. Intrauterine contraception by plastic intrauterine devices. 2 personal cases of failures. [Contraception intra-uterine par les appareils plastiques intra-uterins -- a propos de 2 observations personnelles d'echec.]
  107. Intrauterine contraception.
  108. Intrauterine contraception. [Intrauterine Kontrazeption.]
  109. Intrauterine contraception: a research report.
  110. Intrauterine contraception: a research report.
  111. Intrauterine contraceptive device and its side effects.
  112. The intrauterine contraceptive device and myometrial activity.
  113. The intrauterine contraceptive device and myometrial activity.
  114. Intrauterine contraceptive device-its success and failure.
  115. An introduction to family planning in the context of health services.
  116. Investigation and treatment of amenorrhea developing after treatment with oral contraceptives.
  117. The investigation and treatment of amenorrhea developing after treatment with oral contraceptives.
  118. An investigation of mood states in women taking oral contraceptives.
  119. Investigation of relation between use of oral contraceptives and thromboembolic disease.
  120. Investigations on the effect of an oral contraceptive and its components on liver function, serum proteins, copper, coeruloplasmin and gamma-glutamyl peptidase in postmenopausal women.
  121. Islam and family planning.
  122. IUDs - intrauterine contraceptive devices. [Sterilets - appareils contraceptifs intra-uterins.]
  123. Jamaica: private sector distribution of contraceptives.
  124. Joint monthly report - July and August, 1968: Family planning and population studies programs.
  125. Juridical and legal-political problems of birth control. [Juristische und rechtspolitische Probleme der Geburtenregelung.]
  126. The Korean family planning program in charts.
  127. L.E. cells after oral contraceptives.
  128. L.E. Cells after oral contraceptives.
  129. L.E. cells after oral contraceptives. (Letter to the editor)
  130. Large-scale study of an oral contraceptive.
  131. The law, social welfare and family planning.
  132. Legal aspects of family planning.
  133. Legal responsibilities and liabilities: intrauterine contraceptive devices and oral contraceptives.
  134. The Lippes Loop and other intrauterine contraceptive devices: development and current use.
  135. Liver function studies and progestagen contraception: review of an intramuscularly administered contraceptive.
  136. The liver toxicity of oral contraceptives: a critical review of the literature.
  137. The London letter. Thromboembolism and oral contraceptives.
  138. Long-term contraceptive effect of injectable progestogens: inhibition and reestablishment of fertility.
  139. Long-term effects of oral contraceptives on the ovary and pituitary.
  140. Low dosage progestogens alone and injectable hormonal contraceptives: development and clinical use.
  141. Low-dosage approach to oral contraception.
  142. A low-dosage contraceptive in public health clinics.
  143. Major considerations in the application of satellite communications to India's family planning programme.
  144. Malaysia family-planning centers strive to maintain gains won in 15-year period.
  145. Malaysia: the family planning program, 1967.
  146. Manpower and training problems in family planning programs.
  147. Maternity care and family planning as a world program.
  148. Maximizing citizen participation in family planning programme.
  149. Measurement of family planning progress in Pakistan.
  150. Measurement of motivation for a family planning educational programme.
  151. Mechanism of action of prolonged-action injectable contraceptives. [Mecanismo de accion de los contraceptivos inyectables de deposito.]
  152. Medical and metabolic effects of oral contraceptives and their implications.
  153. Medical aspects of family planning.
  154. Medical complications of contraception: a review.
  155. The medical profession and family planning.
  156. Melasma induced by oral contraceptive drugs.
  157. Mental health aspects of family planning.
  158. Method of action of long-acting parenteral contraceptives.
  159. Method of comparing and contrasting existing methods of contraception.
  160. Methodology in oral contraceptive research.
  161. Methods of family planning. Book 1. Introduction to the methods.
  162. The Mexican urbanization process and its implications (Family planning)
  163. Migraine and oral contraceptives.
  164. Minidose oral contraception and injectable contraception.
  165. Mobile units. (The use of in family planning programs)
  166. Mode of action of contraceptive drugs.
  167. Moroccan family planning program: progress and problems.
  168. Motivation for family planning.
  169. Motivational aspects of resistance to family planning in an Indian village.
  170. Necessity and methods of family planning in industrial and developing countries. [Notwendigkeiten und Methoden der Familienplanung in Industrie- und Entwicklungslaender.]
  171. Neurologic complications of oral contraceptives.

     

  172. Neurological catastrophe related to oral contraceptives.
  173. Neurological symptoms and oral contraceptives.
  174. Neutrophil alkaline phosphatase activity: effect of certain oral contraceptive hormones.
  175. New biological application of contraceptive steroids.
  176. A new form of intrauterine contraceptive device.
  177. New side effect reports with oral contraceptives.
  178. New stainless steel spring for intrauterine contraception.
  179. Occurrence and function of corpora lutea during different forms of oral contraception.
  180. The occurrence of breakthrough bleeding with the use of oral contraceptives.
  181. Occurrence of ectopic pregnancy in women with IUDs and consideration of the contraceptive mechanism of the IUD.
  182. On the effects of family planning communication.
  183. On the importance of family planning: an introduction.
  184. On the mechanism of action of hormonal contraceptives in women.
  185. Ontological and ethical foundations of family planning. [Fundamentos ontologicos y eticos de la planificacion familair.]
  186. Ophthalmologic findings with oral contraceptives.
  187. Opposition to family planning in Latin America: conservation nationalism.
  188. Opposition to family planning in Latin America: conservative nationalism.
  189. Oral and intrauterine contraception: effectiveness and safety.
  190. Oral contraception and elevated blood pressure.
  191. Oral contraception and future fertility.
  192. Oral contraception and the menstrual cycle.
  193. Oral contraception and thromboembolic disease.
  194. Oral contraception and thromboembolic disease.
  195. Oral contraception using a sequential method: a clinical investigation.
  196. Oral contraception with continuous microdosage of norgestrel.
  197. Oral contraception.
  198. Oral contraception.
  199. Oral contraception.
  200. Oral Contraception: combined and sequential preparations.
  201. Oral Contraception: Development and Clinical Use of Combined Preparations.
  202. Oral contraceptive and platelet behavior.
  203. Oral contraceptive and thrombosis of the coeliac artery.
  204. Oral contraceptive drugs and migraine.
  205. The oral contraceptive pill.
  206. Oral contraceptives and alopecia.
  207. Oral contraceptives and caeruloplasmin activity. (Letter)
  208. Oral contraceptives and carbohydrate metabolism.
  209. Oral contraceptives and cell replication.
  210. Oral contraceptives and cell replication. (Letter to the editor)
  211. Oral contraceptives and cell replication. (Letter)
  212. Oral contraceptives and cerebral blood flow.
  213. Oral contraceptives and cerebral blood-flow.
  214. Oral contraceptives and follicle-stimulating hormone.
  215. Oral contraceptives and hypertension: A clinical observation.
  216. Pakistan: the family planning program, 1965-1967.
  217. Paramedical prescription of oral contraceptives. (Abstract only)
  218. Patient acceptance of oral contraceptives. I. The American Indian.
  219. Patterns of program development in family planning.
  220. Perceived probability of success and motivational basis for family planning programme. Part I.
  221. Perceived probability of success and motivational basis for family planning programme. part II.
  222. Perspectives on family planning in Maghrib.
  223. Pharmacology of oral contraceptives.
  224. Physician responsibility in family planning. [La responsabilidad del medico en la planeacion familiar.]
  225. PIA - a comparison of male and female responses relating to knowledge, attitude and practice regarding family planning.
  226. Pigmentation and oral contraceptives.
  227. The place of postpartum sterilization in family planning among the Negro population of Jamaica. (Abstract only)
  228. The place of various contraceptive techniques in a large-scale family planning program.
  229. Planned parenthood - background and development in Sweden.
  230. Planned parenthood in medical education.
  231. Planned Parenthood works with Korean government.
  232. Plasma - zinc and copper in pregnancy and after oral contraceptives.
  233. Population and family planning in Ceylon.
  234. Population and family planning in Japan.
  235. Population and family planning in Malaysia.
  236. Population and family planning programs in U.S. schools of public health.
  237. Population and family planning: the transition from concern to action.
  238. Population and family planning: the transition from concern to action. Report of the President's Committee on Population and Family Planning.
  239. The population challenge: U.S. aid and family planning in the less-developed countries.
  240. Population policy and family planning in Iran.
  241. Population problems and family planning programs in Egypt.
  242. Possible asthmogenic effect of oral contraceptives.
  243. Preparing communications materials for family planning programs.
  244. Present status of communications for family planning in some ECAFE countries.
  245. Presidential address (on family planning in India)
  246. Program planning for family planning.
  247. Progress and problems of family planning in Brazil.
  248. Progress and problems of family planning in the United Arab Republic.
  249. Prolonged amenorrhea following the use of oral contraceptives.
  250. Prolonged oral contraception and its after-effects.
  251. The prospect of family planning in Iran.
  252. Psychiatric reactions to oral contraceptives.
  253. Psychiatric symptoms during the post-partum period as related to use of oral contraceptives.
  254. Psychodynamic aspects of oral contraception.
  255. A psychological analysis of the family planning situation in India.
  256. Psychological and theological problems of oral contraception.
  257. Psychological aspects of legal abortion and contraception.
  258. Psychological aspects of oral contraceptives.
  259. The public health nurse's role in family planning.
  260. Public programs in family planning in the U.S.A.
  261. Puerperal and post-abortal insertion of intrauterine contraceptive devices. (Abstract only)
  262. Pulmonary embolism and oral steroidal contraceptives.
  263. Rapid acceleration of a public health department family planning program: Muscogee County, Georgia.
  264. Recent fertility change in Ceylon and prospects for the National Family Planning Program.
  265. Recent population trends and family planning activity in the Caribbean.
  266. Recent trends in family planning.
  267. Relation between headaches from oral contraceptives and development of endometrial arterioles.
  268. The relative expressed estrogenicity of oral contraceptives.
  269. Reply to letter on family planning and other population controls. (Letter)
  270. Report of the Working Group on Communications Aspects of Family Planning Programmes.
  271. Report on intrauterine contraceptive devices.
  272. Research in progress on birth control. [Recherches en cours dans la regulation des naissances.]
  273. Research studies on abortion and family planning in Colombia.
  274. The responsibility of public welfare in family planning.
  275. Results of vaginal cytodiagnosis on long-term users of a contraceptive tablet containing a surface active agent p-methanylphienyl polyoxyethylen e (i.8) ether (TS-88) as an active ingredient.
  276. Retention of intrauterine contraceptive devices.
  277. Retrospective and prospective aspects of the problem of abortions and family planning in Yugoslavia (author's transl) [Retrospektywne i prospektywne rozwazania nad rozwojem zagadnienia poronien i planowania rodziny w Jugoslawii.]
  278. Reversible "cancer" and the contraceptive pill.
  279. A review of research needs in family planning.
  280. A review, evaluation, and forward look at contraceptive technology.
  281. The rhythm method of family planning limitation.
  282. The rhythm method of family planning.
  283. Rhythm: a hazardous contraceptive method.
  284. Risks of contraception with the intrauterine device. [Letter]
  285. The role of family planning in African development. (Proceedings of a seminar held at University College, Nairobi, Kenya, December 13-16, 1967.)
  286. The role of non-government family planning associations.
  287. The role of paramedical personnel in family planning programmes--with particular reference to intra-uterine devices.
  288. The role of voluntary agencies in the family planning program.
  289. Rural population and family planning. [Poblacion rural y planificacion familiar.]
  290. The San Gregorio experimental family planning program: changes observed in fertility and abortion rates.
  291. Selected works on fertility and family-planning studies in the United States, 1960-1967.
  292. Serum copper alteration after ingestion of an oral contraceptive.
  293. Seven years of clinical experience with a sequential oral contraceptive.
  294. Severe endogenous hypertriglyceridemia during treatment with estrogen and oral contraceptives.
  295. Sexual health and family planning; the seventh annual Bronfman Lecture.
  296. Should we teach about birth control in high school sex education.
  297. Side effects. (oral contraceptives)
  298. Singapore: the national family planning program.
  299. Social and demographic correlates of contraceptive adoption in a rural area of East Pakistan.
  300. Social work practice toward enhancing competence in family planning.
  301. The Social work role in family planning: a summation.
  302. Socio-medical evaluation of intrauterine devices in Railways Family Planning Centre.
  303. Some "marketing correct" recommendations for family planning campaigns.
  304. Some apparently common problems in patients receiving contraceptive pills.
  305. Some aspects of family planning in lower class families.
  306. Some observations on the use of communications media for family planning in Japan.
  307. Some socio-demographic characteristics of women seeking contraceptive advice in one of the southern clinics of Teheran.
  308. Statement of the National Association of Social Workers on Family Planning.
  309. Statistical analyses on microbiology and epithelial cell patterns in women under long-term oral contraceptive medication.
  310. Statistical assessment of adverse experiences associated with the use of oral contraceptives.
  311. Statistical evaluation of contraceptive methods: use-effectiveness and extended use-effectiveness.
  312. Steroid contraceptives; a review.
  313. Studies in family planning communications in India.
  314. Studies of "mini-micro" contraceptive doses of a new progestogen.
  315. Studies on the mode of action of intrauterine contraceptive device with the use of closed circuit television hysterofluorography.
  316. Studies on the mode of action of oral contraceptives: effect of chlormadinone on pituitary FSH and LH contents of the female rat.
  317. Studies on the site of action of oral contraceptive steroids: 1. Effect of antifertility steroids on plasma LH levels and on the response to luteinizing hormone-releasing factor in rats.
  318. A study of the contraceptive effect and side effects of a surface active agent, E-136.
  319. Summary and implications of the Institute for the social work community in relation to family planning.
  320. Sunlight sensitivity from oral contraceptives.
  321. Survey of the sales of contraceptives by pharmacies of Dacca, East Pakistan.
  322. Survey on Family Planning in Calcutta, November 1968.
  323. Survey on family planning in the prenatal care center of the compulsory social service center in Antimano. [Encuesta sobre planificacion familiar en la consulta prenatal del centro del seguro social obligatorio en Antimano.]
  324. Taiwan's family planning program.
  325. Taiwan: training for family planning.
  326. The tasks of family planning in the European Region of the International Planned Parenthood Federation - IPPF. [Aufgaben der Familienplanung in der europaischen Region der Internationalen Foderation fur geplante Elternschaft - IPPF.]
  327. Techniques for overcoming community resistance to family planning programs.
  328. Ten years of family planning on tea estates in Assam.
  329. The terrible trouble with the birth-control pills.
  330. Therapuetic and contraceptive use of oral progestagens. [Terapevticheskoe i kontratseptivnoe primenenie oralynykh progestagenov.]
  331. Thoughts on India's most pressing problems--population control and sound family planning.
  332. Thromboembolic disease and oral contraceptives.
  333. Thromboembolism during oral contraception. A critical review of the literature. [Trombo-emboli ved oral antikonception. En kritisk litteraturoversigt.]
  334. Thrombosis of the retinal artery and oral contraceptives. [Thrombose arterielle retinienne et contraceptifs oraux.]
  335. Toxicological requirement of oral contraceptives.
  336. Transitory vascular-like phenomena with the use of oral contraceptive.
  337. Trial of a long-acting, injectable contraceptive as a substitute for the IUCD and the pill in a remote region of Thailand.
  338. Trial with oral contraceptives in Calcutta Medical College Hospital.
  339. Tunisia's experience in family planning.
  340. Two years' clinical experience with norethisterone enanthate as a prolonged-action injectable contraceptive. [Dos anos de experiencia clinica con el enantato de noretisterona como an ticonceptivo inyectable de deposito.]
  341. U.N. activities in the family planning field.
  342. U.N.E.S.C.O. and the family planning programme.
  343. Couple concurrence and empathy on birth control motivation in Dacca, East Pakistan.
  344. Endometrial histology associated with an intrauterine contraceptive device.
  345. The haemostatic mechanism in oral contraception.
  346. Measuring acceptances in a family planning program: the decomposition of rates by eligibility criteria.
  347. On endocrine effects of oral contraceptives.
  348. Postwar movement and programme for family planning.
  349. Poverty and family planning in the United States: some social and psychological aspects and implications for programs and policy.
  350. Prescribing contraception for teenagers: a moral compromise?
  351. Proceedings of the Eighth International Conference of the International Planned Parenthood Federation, Santiago, Chile, 9-15 April 1967.
  352. Process of birth control. [Abstract]
  353. A program in mass family planning for the urban indigent in a charity hospital.
  354. Programme building operations for promotion of family planning: the Indian Statistical Institute clinic experiment.
  355. Pseudo-carcinoma of the cervix in patients who are taking oral contraceptives.
  356. Psychological factors influencing female patients in the selection of contraceptive devices.
  357. Psychosis associated with the use of a sequential oral contraceptive.
  358. Pulmonary embolization and oral contraceptive.
  359. The quiet revolution: family planning in India.
  360. Recent progress on systemic contraceptives.
  361. Recent studies of hormonal contraceptives in long-term application. Abstract only)
  362. Report from five Swiss centres on two comparative trials with oral contraceptives.
  363. The research challenge to social scientists in the developing family planning programs: the case of Taiwan.
  364. The results of a field-test on the contraceptive tablet with TS-88 as the main ingredient.
  365. Resumption of ovulation after discontinuing oral contraception.
  366. Retinal edema secondary to oral contraceptives.

     

  367. Return of ovulation after discontinuance of oral contraceptives.
  368. A review of an oral contraceptive, Lyndiol 2.5.
  369. Review of the family planning action program in the Republic of Korea.
  370. The rhythm method of birth control.
  371. The rights and duties of the doctor in contraception, sterilisation and abortion.
  372. Risk of thromboembolic disease in women taking oral contraceptives. A preliminary communication to the Medical Research Council by a Subcommittee.
  373. Roles and activities of the International Planned Parenthood Federation.
  374. The 2 hour sulfebremophthalein retention test and the transaminase activity during oral contraceptive therapy.
  375. Abortion, sterilization, and contraception: experiences with Mothers' Aid Centers in Denmark.
  376. Achilles tendon reflex to evaluate thyroid function during pregnancy and in subjects taking oral contraceptives.
  377. Action-research in one-time family planning methods: outline of a plan for West Bengal. [Abstract]
  378. An action-research project on family planning in poverty neighborhoods of New York City. [Abstract]
  379. Administration of a family planning programme.
  380. Africa and the problem of contraception.
  381. After office hours: acceptance of pregnancy before and since oral contraception.
  382. Alopecia from oral contraceptives.
  383. Alpha amylase content in cervical mucus of females receiving sequential, nonsequential, or no contraceptive therapy.
  384. Alterations in serum naphthlamidase isozymes during treatment with oral contraceptives.
  385. Angioneurotic edema from an oral contraceptive.
  386. Anicteric hepatitis and oral contraceptives.
  387. Appendix One. [Family planning voluntary organizations; related organizations (government and voluntary); major contraceptive manufacturers]
  388. Application of a theory of rural development to family planning in East Pakistan.
  389. Application of learning theory to a family planning programme in Dacca, East Pakistan.
  390. Applications of the behavioral sciences to family planning programs.
  391. Aspects of family planning among low income, "high-risk" mothers.
  392. Assistance for family planning programs in developing countries.
  393. Attitude studies relating to family planning in India. [Abstract]
  394. Attitudes on family planning.
  395. Attitudes towards planned parenthood.
  396. Atypical endocervical hyperplasia in women taking oral contraceptives.
  397. Barrier methods of contraception.
  398. Bibliography on the relationship between the oral contraceptive pill and its effect upon the menstrual period.
  399. Biochemical findings in long-term oral contraceptive usage. I. Liver function studies.
  400. The Birnberg bow as an intrauterine contraceptive device.
  401. Birth control and new constitutional concepts of freedom.
  402. Birth control and psychoprophylactic confinement school of freedom.
  403. Birth control in some of the developing countries of the Far East.
  404. Birth control measures and their influence on population replacement.
  405. Birth control.
  406. Budd-Chiari syndrome after taking oral contraceptives.
  407. Canadian county-sponsored family planning. I. Organization.
  408. Canadian county-sponsored family planning. II. Twelve-month review.
  409. A case of multiple arterial thromboses after oral contraceptive and ergotamine.
  410. Cerebral arterial insufficiency and oral contraceptives.
  411. Cerebral thrombosis and oral contraception. (Letter to the editor)
  412. Cerebrovascular disease in young women taking oral contraceptives.
  413. Chemical aspects of steroidal contraceptives. [Aspect chimique des contraceptifs steroidiques.]
  414. The Chicago snowball: a study of the flow and diffusion of family planning information.
  415. China: the changing status of women, literacy and education and family planning.
  416. Chloasma and the contraceptive pill.
  417. Chlormadinone acetate: an oral contraceptive.
  418. The choice of an oral contraceptive.
  419. Chromosomes after oral contraception.
  420. Chromosomes after oral contraceptives.
  421. Clinical criticism of the oral contraceptive pills.
  422. Clinical evaluation of a new sequential oral contraceptive agent.
  423. Clinical experience with a prolonged-action injectable hormonal contraceptive. [Experiencia clinica con un anticonceptivo hormonal inyectable de deposito.]
  424. The clinical meaning of the long-term side effects as seen in experiments with 19-nor-contraceptives.
  425. Clinical studies on oral contraceptives: a randomized, doubleblind, crossover study of 4 different preparations (Anovlar mite, Lyndiol mite, Ovulen, and Volidan)
  426. Clinical study of WY-3707 and ethinyl estradiol as an oral contraceptive.
  427. A clinical trial of a new low dose oral contraceptive compound.
  428. A clinical trial of the progestational steroid ethynodiol diacetate as an oral contraceptive.
  429. The coagulation mechanism in oral contraception.
  430. Combined histologic and cytologic study of intrauterine contraception.
  431. Communication in family planning: report on an experiment.
  432. Comparison of long-term effectiveness of intra-uterine devices and oral contraceptives.
  433. Comparison of three contraceptive methods: diaphragm with jelly or cream, vaginal foam, and jelly/cream alone.
  434. Contraception and Catholicism in Latin America.
  435. Contraception and industrial medicine.
  436. Contraception and misconceptions.
  437. Contraception control (round-table discussion)
  438. Contraception in ancient Egypt.
  439. Contraception in the third world. [La contracepcion en el tercer mundo.]
  440. Contraception in Turkey.
  441. Contraception with a simple intrauterine device.
  442. Contraception with microdoses of a new progestin (Quingestanol). (Abstract only)
  443. Contraception.
  444. Contraception: the pill.
  445. Contraceptive data on Norgestrel (Wyeth 3707) 0.5 mg together with ethinyl oestradiol 0.05 mg.
  446. A contraceptive injection study.
  447. Contraceptive pills.
  448. Contraceptive polyps miscast as Ca: pathologists warn against faulty diagnosis of tumor that affects more and more women who take the pill.
  449. A contraceptive programme in a Latin American urban community: policy, objectives and facts. [Abstract]
  450. Contraceptives and lactation.
  451. Contraceptives: how they have affected the health, emotions and future children of millions of American women.
  452. Control of postpartum breast engorgement with oral contraceptives.
  453. Correlates of males' attitudes towards family planning.
  454. A critical evaluation of national family planning programmes.
  455. A cross-cultural content analysis of family planning publications.
  456. Cytologic changes following the use of oral contraceptives.
  457. Daily progestogen for contraception: a clinical study.
  458. Demographic and family planning research needs for less-developed areas.
  459. Depo-Provera (medroxyprogesterone acetate) as a female contraceptive agent.
  460. Depo-provera as an injectable female contraceptive agent.
  461. A domiciliary birth control service in Southampton.
  462. The economic case for birth control.
  463. Effect of administration of a combined estrogen-progestin contraceptive on the level of individual plasma proteins.
  464. Effect of an oral contraceptive immediately post partum on initiation of lactation.
  465. Effect of intrauterine contraceptive device on pregnancy.
  466. Effect of Lyndiol, an oral contraceptive, on breast cancer.
  467. Effect of oral contraception on lactation.
  468. Effect of oral contraceptives on haemoglobin, packed-cell volume, serum-iron, and total iron-binding capacity in healthy women.
  469. The effect of oral contraceptives on serum enzymes.
  470. Effect of oral contraceptives on the mental state of women.
  471. Effect of oral contraceptives on the variations in serum-iron during the menstrual cycle.
  472. Effect of oral contraceptives on vitamin-K-dependent clotting activity.
  473. Effect of the IUD and other contraceptive methods on lactation.
  474. Effectiveness of the temperature rhythm system of contraception.
  475. Effectiveness, acceptability and safety of modern contraceptive methods.
  476. Effects of an oral contraceptive on ovarian reaction to human gonadotropins. [Effets d'un contraceptif oral sur la reaction ovarienne aux gonadotrophines humaines.]
  477. The effects of birth control measures on sex and marriage.
  478. Effects of contraceptive hormone preparations on the fine structure of the endometrium.
  479. Effects of different contraceptives upon the ovulation changes of the morphological study of the ovaries. [Efectos de diversos contraceptivos sobre la ovulacion a traves del estudio morfologico del ovario.]
  480. Effects of family planning on poverty in the United States.
  481. Effects of oral contraceptives.
  482. The effects of race and socio-economic status on family planning.
  483. Effects of various contraceptive agents on ovulation investigated by morphological study of the ovary. (Abstract only)
  484. Egyptian contraception.
  485. Endometrial enzyme histochemistry in oral contraceptive therapy.
  486. Endometrial histology and clinical symptoms following prolonged retention of uterine contraceptive devices.
  487. Epidemiologic and experimental aspects of oral contraceptives.
  488. Erythema nodosum and contraceptive medication.
  489. Estimated reductions in birth rate resulting from different combinations of sterilization and contraception programmes in India. [Abstract]
  490. Evaluation of a family planning programme in China (Taiwan)
  491. Evaluation of a family planning publicity program in India.
  492. Evaluation of an oral contraceptive: thynodiol diacetate with mestranol (Ovulen)
  493. Evaluation of family planning programme in India.
  494. Evaluation of intrauterine contraceptive devices.
  495. Evaluation of megestrol acetate and ethinyl estradiol as an oral contraceptive.
  496. Evaluation of oral contraceptives.
  497. Evaluation of programme objectives in family planning.
  498. Evaluation of Tunisia's family planning programme.
  499. Exhibition as a method of communication in family planning.
  500. The experimental results of an effervescent contraceptive tablet, containing the new surface active agent, TS-88 as the main ingredient.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.